| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes TF ADVANCE Collaborative Group, Patel A, MacMahon S New England Journal of Medicine 358 (24), 2560-72, 2008 | 10102 | 2008 |
| The transcriptional landscape of the mammalian genome P Carninci, T Kasukawa, S Katayama, J Gough, MC Frith, N Maeda, ... science 309 (5740), 1559-1563, 2005 | 4038 | 2005 |
| Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs RIKEN Genome Exploration Research Group Phase I Team: Carninci P. 2 Hayatsu ... Nature 420 (6915), 563-573, 2002 | 2161 | 2002 |
| Vaccine adjuvants: current state and future trends N Petrovsky, JC Aguilar Immunology and cell biology 82 (5), 488-496, 2004 | 1364 | 2004 |
| The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line Nature genetics 41 (5), 553-562, 2009 | 429 | 2009 |
| Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications N Petrovsky, P McNair, LC Harrison Cytokine 10 (4), 307-312, 1998 | 410 | 1998 |
| Inulin-a versatile polysaccharide with multiple pharmaceutical and food chemical uses T Barclay, M Ginic-Markovic, P Cooper, N Petrovsky International Journal of Pharmaceutical Excipients 1 (3), 2016 | 409 | 2016 |
| Will blockchain technology revolutionize excipient supply chain management? S Apte, N Petrovsky Journal of Excipients and Food Chemicals 7 (3), 76-78, 2016 | 394 | 2016 |
| Technologies for enhanced efficacy of DNA vaccines F Saade, N Petrovsky Expert review of vaccines 11 (2), 189-209, 2012 | 384 | 2012 |
| Molecular mechanisms for enhanced DNA vaccine immunogenicity L Li, N Petrovsky Expert review of vaccines 15 (3), 313-329, 2016 | 368 | 2016 |
| Review of polysaccharide particle-based functional drug delivery TG Barclay, CM Day, N Petrovsky, S Garg Carbohydrate polymers 221, 94-112, 2019 | 360 | 2019 |
| Comparative safety of vaccine adjuvants: a summary of current evidence and future needs N Petrovsky Drug safety 38 (11), 1059-1074, 2015 | 357 | 2015 |
| The chronobiology of human cytokine production N Petrovsky, LC Harrison Cytokines and Cytokine Receptors, 810-824, 2001 | 300 | 2001 |
| Towards a unified model of neuroendocrine–immune interaction N Petrovsky Immunology and cell biology 79 (4), 350-357, 2001 | 276 | 2001 |
| The future of human DNA vaccines L Li, F Saade, N Petrovsky Journal of biotechnology 162 (2-3), 171-182, 2012 | 252 | 2012 |
| Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic … Y Honda-Okubo, D Barnard, CH Ong, BH Peng, CTK Tseng, N Petrovsky Journal of virology 89 (6), 2995-3007, 2015 | 246 | 2015 |
| Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? N Petrovsky, LC Harrison Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5163-5168, 1997 | 231 | 1997 |
| Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications V Brusic, VB Bajic, N Petrovsky Methods 34 (4), 436-443, 2004 | 229 | 2004 |
| Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses Y Honda-Okubo, F Saade, N Petrovsky Vaccine 30 (36), 5373-5381, 2012 | 197 | 2012 |
| Methods for prediction of peptide binding to MHC molecules: a comparative study K Yu, N Petrovsky, C Schönbach, JLY Koh, V Brusic Molecular medicine 8, 137-148, 2002 | 193 | 2002 |
